| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |